Add Formweb to your mobile device
Search results for:
inFLIXimab
inFLIXimab
Brand names: Avsola, Inflectra, Remicade, Renflexis
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| POWDER FOR INJECTION, INTRAVENOUS | 100 mg; abda 100 mg; axxq 100 mg; dyyb 100 mg |
VIEW MORE GI Drugs, Miscellaneous, Skin and Mucous Membrane Agents, Miscellaneous, Immunomodulatory Agents, Disease-Modifying Antirheumatic Drugs
CLASS
CLASS
569200, 849200, 922000, 923600
Last updated: May. 1, 2024
- Black Box Warning: Serious infection risk; hepatosplenic t-cell lymphomas; malignancy
- Therapeutic Interchange: Biosimilar and Reference Products Conversion List for Adults
- Do Not Tube-LALK
- Restricted: inFLIXimab is restricted to the Outpatient setting except for Inpatient use by gastroenterologists in patients with Crohn's disease or ulcerative colitis who are nearing obstruction
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines
(Note: “Therapeutic Interchange” should be placed in the order comments)
Biosimilar and Reference Products Interchange List for Adults
Medication
Reference Drug or Biosimilar
Formulary Status
Automatic Therapeutic Interchange
Inpatient1
Outpatient
*New Starts/New Authorizations Only*
Renflexis (infliximab-abda)
Biosimilar
Formulary
(preferred)
Use Renflexis
Use Renflexis unless third party payer requires other infliximab product
Inflectra (infliximab-dyyb)
Avsola (infliximab-axxq)
Biosimilars
Formulary, restricted to OP
(not preferred)
Interchange to Renflexis
Interchange to Renflexis unless third party payer requires other infliximab product
Remicade or generic (infliximab)
Reference